CIK: 0001381843 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 6, 2026
Total Value ($000): $313,442 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 106,518 | $8,453 | 2.7% | $78.67 | 0.0% | COM | 126650100 |
| IONS | IONIS PHARMACEUTICALS INC | 92,377 | $7,308 | 2.3% | $75.30 | 0.0% | COM | 462222100 |
| INCY | INCYTE CORP | 70,851 | $6,998 | 2.2% | $96.76 | 0.0% | COM | 45337C102 |
| INSM | INSMED INC | 27,873 | $4,851 | 1.5% | $182.48 | 0.0% | COM PAR $.01 | 457669307 |
| ABVX | ABIVAX SA | 31,590 | $4,260 | 1.4% | $134.85 | — | SPONSORED ADS | 00370M103 |
| IDYA | IDEAYA BIOSCIENCES INC | 97,438 | $3,368 | 1.1% | $31.88 | 0.0% | COM | 45166A102 |
| CMPX | COMPASS THERAPEUTICS INC | 584,332 | $3,138 | 1.0% | $4.62 | 0.0% | COM | 20454B104 |
| PYXS | PYXIS ONCOLOGY INC | 617,245 | $710 | 0.2% | $3.53 | 0.0% | COMMON STOCK | 747324101 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ABBV | AbbVie Inc | 108,181 (+17.5%) | $24,718 (+991.8%) | 7.9% | $176.08 | +29.2% | COM | 00287Y109 |
| MRK | Merck & Co. Inc | 195,768 (+21.7%) | $20,607 (+1337.2%) | 6.6% | $98.68 | -5.5% | COM | 58933Y105 |
| TMO | Thermo Fisher Scientific Corp | 29,915 (+10.2%) | $17,334 (+1140.1%) | 5.5% | $519.30 | +8.8% | COM | 883556102 |
| ISRG | Intuitive Surgical Inc | 22,322 (+13.3%) | $12,642 (+1251.1%) | 4.0% | $542.50 | -1.9% | COM NEW | 46120E602 |
| ONC | BEONE MEDICINES LTD-ADR | 40,432 (+33.3%) | $12,284 (+1019.6%) | 3.9% | $222.26 | — | SPONSORED ADS | 07725L102 |
| VRTX | Vertex Pharmaceuticals Inc | 22,984 (+29.4%) | $10,420 (+1310.6%) | 3.3% | $422.97 | +1.9% | COM | 92532F100 |
| BSX | Boston Scientific Corp | 108,682 (+25.4%) | $10,363 (+1053.5%) | 3.3% | $74.66 | +31.3% | COM | 101137107 |
| SYK | Stryker Corporation | 26,835 (+17.9%) | $9,432 (+955.5%) | 3.0% | $324.64 | +12.0% | COM | 863667101 |
| RVMD | REVOLUTION Medicines Inc | 90,184 (+5.7%) | $7,183 (+1597.4%) | 2.3% | $47.24 | +38.8% | COM | 76155X100 |
| AMGN | Amgen Inc | 21,903 (+58.6%) | $7,169 (+1633.3%) | 2.3% | $285.23 | +10.8% | COM | 031162100 |
| NAMS | NewAmsterdam Pharma Co NV | 197,036 (+1.8%) | $6,912 (+1082.3%) | 2.2% | $19.94 | +82.5% | ORDINARY SHARES | N62509109 |
| IRTC | iRhythm Technologies Inc | 37,579 (+25.3%) | $6,668 (+1117.7%) | 2.1% | $129.88 | +36.4% | COM | 450056106 |
| CELC | CELCUITY INC | 41,831 (+12.6%) | $4,172 (+2041.0%) | 1.3% | $44.74 | +83.7% | COM | 15102K100 |
| IRON | Disc medicine inc | 47,967 (+5.0%) | $3,809 (+1088.4%) | 1.2% | $54.24 | +55.8% | COM | 254604101 |
| UNH | Universal Health Services Inc | 14,636 (+6.6%) | $3,191 (+971.0%) | 1.0% | $492.66 | -31.6% | COM | 91324P102 |
| ACLX | Arcellx Inc | 41,717 (+62.1%) | $2,720 (+1112.7%) | 0.9% | $67.60 | +18.0% | COMMON STOCK | 03940C100 |
| SLNO | Soleno Therapeutics Inc | 62,735 (+4.3%) | $2,905 (+572.8%) | 0.9% | $58.22 | -5.8% | COM | 834203309 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| EW | Edwards Lifesciences Corp | 65,659 | $542 | 0.2% | $74.44 | +10.2% | — | 28176E108 |
| — | Merus N.V. | 47,999 | $480 | 0.2% | $45.53 | — | — | N5749R100 |
| HRMY | Harmony Bioscience Holdings | 92,074 | $269 | 0.1% | $33.66 | -2.3% | — | 413197104 |
| RNA | Avidity Biosciences Inc | 51,978 | $240 | 0.1% | $40.43 | +59.8% | — | 05370A108 |
| SMMT | Summit Therapeutics Inc | 92,737 | $203 | 0.1% | $14.99 | +25.5% | — | 86627T108 |
| MREO | Mereo Biopharma Group PLC | 764,901 | $167 | 0.1% | $3.28 | — | — | 589492107 |
| JANX | Janux Therapeutics Inc | 49,820 | $129 | 0.0% | $49.08 | -52.1% | — | 47103J105 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly & Co | 31,133 (-16.4%) | $33,458 (+1009.0%) | 10.7% | $707.31 | +35.1% | COM | 532457108 |
| NBIX | Neurocrine Biosciences Inc | 94,796 (-7.6%) | $13,445 (+779.1%) | 4.3% | $130.83 | +10.7% | COM | 64125C109 |
| BBIO | Bridgebio Pharma Inc | 141,296 (-19.1%) | $10,808 (+1021.8%) | 3.4% | $31.34 | +109.5% | COM | 10806X102 |
| KRYS | Krystal Biotech, Inc | 33,853 (-19.8%) | $8,346 (+955.5%) | 2.7% | $151.49 | +38.9% | COM | 501147102 |
| COR | Cencora Inc | 23,773 (-16.9%) | $8,029 (+745.9%) | 2.6% | $208.00 | +63.8% | COM | 03073E105 |
| MIRM | Mirum Pharmaceuticals Inc | 89,685 (-4.2%) | $7,084 (+872.4%) | 2.3% | $36.30 | +97.7% | COM | 604749101 |
| ALKS | Alkermes PLC | 242,473 (-4.1%) | $6,784 (+742.4%) | 2.2% | $26.70 | +12.2% | SHS | G01767105 |
| GILD | Gilead Sciences Inc | 50,796 (-35.0%) | $6,235 (+576.8%) | 2.0% | $101.28 | +19.4% | COM | 375558103 |
| CAH | Cardinal Health Inc | 23,470 (-22.5%) | $4,823 (+855.3%) | 1.5% | $78.17 | +140.1% | COM | 14149Y108 |
| DXCM | Dexcom Inc | 39,722 (-21.9%) | $2,636 (+625.4%) | 0.8% | $97.28 | -33.5% | COM NEW | 252131107 |
| BCAX | BICARA THERAPEUTICS INC | 111,363 (-45.3%) | $1,874 (+448.7%) | 0.6% | $12.52 | +36.4% | COM | 055477103 |
| CRBP | Corbus Pharmaceuticals Holding | 107,255 (-38.9%) | $873 (+270.2%) | 0.3% | $20.42 | -39.6% | COM | 21833P301 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| UFPT | UFP Technologies Inc | 22,986 | $5,104 | 1.6% | $277.76 | -22.9% | COM | 902673102 |
| AUTL | Autolus Therapeutics PLC | 1,169,634 | $2,328 | 0.7% | $2.89 | — | SPON ADS | 05280R100 |